International Myeloma Society 6th Immune Effector Cell Therapies in Multiple Myeloma Workshop 2025
Include: 9 videos + 1 pdf, size: 9.91 GB
Target Audience: hematologists, oncologists treating multiple myeloma
Information:
The 6th Immune Effector Cell Therapies in Multiple Myeloma Workshop is an advanced two-day educational event dedicated to the latest innovations in immune-based treatments for multiple myeloma. This workshop delivers in-depth scientific updates alongside practical, case-driven discussions to help participants optimize clinical outcomes.
What You Will Learn
Latest clinical trial data on CAR T-cell therapies targeting BCMA and GPRC5D
Advances in bispecific antibodies and T-cell engagers, including teclistamab, elranatamab, talquetamab, and others
Strategies to manage toxicities such as cytokine release syndrome, cytopenias, and organ-specific complications
Emerging therapies: allogeneic CAR T, CAR-NK cells, dual antigen targeting, and trispecific antibodies
Approaches to overcome resistance and enhance treatment response through combination regimens and immune modulation
Event Details
Dates: March 28–29, 2025
Location: Boston Marriott Long Wharf, Boston, Massachusetts
Who Should Attend
This workshop is ideal for:
Hematologists and oncologists treating multiple myeloma
Clinical researchers and trial investigators in immune therapy
Advanced practice providers and pharmacists involved in immune effector cell therapy care
Industry professionals and academic experts interested in translating research into clinical practice
Why Attend
Gain comprehensive insights into the latest immune effector cell therapy developments
Learn practical management strategies for complex therapy-related toxicities
Network with global leaders and peers in the myeloma research community
Apply cutting-edge scientific knowledge directly to patient care
Topics:
- IEC2025Program.pdf
SESSION 1 CLINICAL UPDATES ON CAR T CELLS.mp4
SESSION 2 CLINICAL UPDATES ON BISPECIFIC ABS TCE’S.mp4
SESSION 3 PRACTICAL CONSIDERATIONS FOR IMMUNE THERAPY.mp4
SESSION 4 NOVEL APPROACHES IN THE CLINIC.mp4
SESSION 5 MANAGING TOXICITIES OF T CELL ENGAGING THERAPIES.mp4
SESSION 6 CORRELATES OF RESPONSE AND RESISTANCE.mp4
SESSION 7 STRATEGIES TO IMPROVE IMMUNE EFFECTOR CELL THERAPIES.mp4
SESSION 8 KEY QUESTIONS IN IMMUNE THERAPY.mp4
WORKSHOP ON SECONDARY MALIGNANCIES AND NON-RELAPSE MORTALITY.mp4
